Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
28 studies found for:    Open Studies | "Telangiectasis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Institutional Registry of Haemorrhagic Hereditary Telangiectasia
Condition: Haemorrhagic Hereditary Telangiectasia
Intervention:
2 Recruiting Topical Brimonidine to Reduce Inflammation After IPL-treatment in Patients With Facial Telangiectasias
Condition: Telangiectasias
Interventions: Drug: Brimonidine;   Other: IPL+air-cooling
3 Recruiting Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept
Condition: Hereditary Hemorrhagic Telangiectasia
Interventions: Drug: Topical timolol maleate;   Drug: placebo saline drops
4 Recruiting Evaluation of Pazopanib on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia
Condition: Telangiectasia, Hereditary Hemorrhagic
Interventions: Drug: Pazopanib;   Drug: Placebo
5 Recruiting Symptoms and Treatment Results in Hereditary Hemorrhagic Telangiectasia
Condition: Hereditary Haemorrhagic Telangiectasia (HHT)
Intervention: Other: questionnaire
6 Recruiting Cerebral Hemorrhage Risk in Hereditary Hemorrhagic Telangiectasia
Condition: Hereditary Hemorrhagic Telangiectasia
Intervention:
7 Recruiting Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - (TEMPO)
Condition: Hemorrhagic Hereditary Telangiectasia (HHT)
Interventions: Drug: Timolol nasal spray;   Drug: Placebo nasal spray
8 Recruiting Iron Deficiency and Hereditary Haemorrhagic Telangiectasia
Condition: Hereditary Haemorrhagic Telangiectasia
Intervention: Drug: Ferrous sulphate 200mg oral tablet
9 Recruiting Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families
Condition: Telangiectasia, Hereditary Hemorrhagic
Intervention:
10 Recruiting Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone
Condition: Ataxia-Telangiectasia
Interventions: Drug: Metformin;   Drug: Pioglitazone
11 Recruiting QOL Assessment in Breast Cancer Patients With Radiation-Induced Telangiectasias Treated With the Pulsed Dye Laser
Conditions: Breast Cancer;   Radiation-Induced Telangiectasias
Intervention: Behavioral: questionnaires
12 Recruiting Case Notes Review on Patients With Hereditary Haemorrhagic Telangiectasia
Condition: Telangiectasia, Hereditary Hemorrhagic
Intervention:
13 Recruiting Cell-Based Approaches For Modeling and Treating Ataxia-Telangiectasia
Condition: Ataxia-Telangiectasia (A-T)
Interventions: Other: with gene correction;   Other: without gene correction
14 Recruiting MRA With Feraheme in HHT
Condition: Hereditary Hemorrhagic Telangiectasia
Intervention: Procedure: Feraheme MRI/MRA
15 Not yet recruiting Treatment of Nasal Staphylococcus Aureus Colonization in Patients With HHT
Conditions: Hereditary Hemorrhagic Telangiectasia;   Epistaxis
Interventions: Drug: Mupirocin;   Other: Placebo
16 Recruiting Graded TTCE for Post-Embolization PAVM Monitoring
Condition: Hereditary Hemorrhagic Telangiectasia (HHT)
Intervention: Other: Transthoracic Contrast Echocardiogram
17 Recruiting Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With (HHT)
Conditions: Hereditary Hemorrhagic Telangiectasia (HHT);   Epistaxis
Interventions: Drug: Floseal;   Other: Packing
18 Recruiting Immunmodulation in Patients With HHT
Condition: Hereditary Haemorrhagic Telangiectasia (HHT)
Intervention: Other: blood sample
19 Not yet recruiting EDS in Ataxia Telangiectasia Patients
Conditions: Nervous System Disease;   Genetic Disease;   Rare Disease
Interventions: Drug: EDS-EP dose range of ~5-10 mg DSP/infusion;   Drug: EDS-EP dose range of ~14-22 mg DSP/infusion;   Drug: Placebo
20 Recruiting Genetic Factors of Idiopathic Polypoidal Vasculopathies in the ATM Gene (Ataxia Telangiectasia Mutated)
Condition: Choroidal Neovascularization
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.